Active ingredient
Natalizumab NDC Codes
Natalizumab is an active ingredient in 2 finished products listed with the FDA, under 2 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Labelers
- Sandoz Inc, Biogen Inc.
- Strengths
- Natalizumab 300 mg/15mL
- Dosage forms
- Injection
- Routes
- Intravenous
- Drug classes (FDA established)
- Integrin Receptor Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 2
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Tyrukonatalizumab-sztn | Natalizumab 300 mg/15mL | InjectionIntravenous | Sandoz Inc | 61314-543 | 61314-0543-94 | — |
| Tysabrinatalizumab | Natalizumab 300 mg/15mL | InjectionIntravenous | Biogen Inc. | 64406-008 | 64406-0008-01 | — |
Natalizumab: common questions
- Which drugs contain Natalizumab?
- Tyruko, Tysabri.
- Is there a J-code for Natalizumab?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.